ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Evraz Group

Evraz Group (XS0808638612)

103.53
0.00
( 0.00% )
Updated: 20:00:00
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
103.53
Bid
103.53
Ask
103.53
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
103.53
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

XS0808638612 Latest News

MonoSol Rx Appoints James S. Scibetta to Board of Directors

WARREN, N.J., April 11, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® technology to develop and bring to market products that improve patient...

HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer Index

NEW YORK, Oct. 23 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the...

Bioenvision Shareholders Approve Acquisition by Genzyme Corporation

CAMBRIDGE, Mass., and NEW YORK, Oct. 22 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and Bioenvision, Inc. (NASDAQ:BIVN) announced this afternoon that Bioenvision stockholders...

Delaware Court Approves Bioenvision, Genzyme Joint Petition

Special Meeting to be Reconvened on October 22 NEW YORK and CAMBRIDGE, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Bioenvision, Inc. (NASDAQ:BIVN) and Genzyme Corporation (NASDAQ:GENZ) announced...

Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share

CAMBRIDGE, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) confirmed today that it will not change its purchase price for Bioenvision (NASDAQ:BIVN) at $5.60 in cash...

Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company

Major Shareholder Will NOT Vote for Merger; Says 'Shareholders Have Already Spoken' by Rejecting Tender Offer at $5.60 per Share NEW YORK, Sept. 6 /PRNewswire-FirstCall/ -- Elliott Associates...

Bioenvision Provides Evoltra(R) (clofarabine) Regulatory Update

Bioenvision, Inc. (Nasdaq:BIVN) today announced an update on the status of its Marketing Authorization Application to the European Medicines Evaluation Agency (EMeA) to include...

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.

OKLAHOMA CITY, July 27 /PRNewswire/ -- On July 13, 2007, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Bioenvision, Inc...

Bioenvision, Inc. Says Securities Class Action Litigation Without Merit

Bioenvision, Inc. (Nasdaq:BIVN) today announced that it has been named as a defendant in a securities class action lawsuit filed in the United States District Court for the...

Dr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of Directors

Bioenvision, Inc. (Nasdaq:BIVN) today announced that Dr. Andrew N. Schiff and Mr. Steven A. Elms have resigned from the Company?s Board of Directors effective as of July 13...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FQHIteris Inc
6.34 €
(62.15%)
104
9960Renergen Limited
0.65 €
(51.87%)
31.5k
G4UGlobe Metals and Mining Ltd
0.032 €
(45.45%)
100k
VBXVoltabox AG
1.515 €
(38.99%)
78.31k
2MAMarin Software Inc
2.22 €
(34.55%)
5.01k
6LGAVicinity Motor Corp
0.1505 €
(-44.05%)
33.97k
CNWCodon AG
0.0095 €
(-34.48%)
611
WS90Provaris Energy Ltd
0.0102 €
(-28.17%)
13.5k
Y920Trilogy AI Corp
0.0601 €
(-27.94%)
20k
MKQMitek Sys Inc Dl 001
7.50 €
(-27.61%)
3.59k
DRHDroneShield Limited
0.689 €
(5.35%)
2.63M
D7GNel ASA
0.4749 €
(2.19%)
1.05M
VAR1Varta AG
2.758 €
(25.36%)
964.09k
VODIVodafone Group plc
0.864 €
(1.31%)
936.01k
HRJ1Sienna Resources Inc
0.0284 €
(11.81%)
723k

Discussion

View Full Feed
sortagreen sortagreen 53 seconds ago
"You know, I wasn't sure who I was going to vote for in November, but TFG has convinced me that he's the better choice."

🤣🤣🤣
jonestint jonestint 59 seconds ago
I love it! You cracked and responded just as I knew you would. Hahahaha!!!!! I absolutely love how I called out this scam 18 months ago on Wednesday, February 22, 2023 while selling MILLIONS of shares to you, effectively creating the high of .1283 the following day, and saying this:

M
CLNV
Mark Mark 1 minute ago
$HUGE .15 new pm highs
HUGE
learningcurve2020 learningcurve2020 2 minutes ago
So, I see what you mean now -not the 13's but SIO's own report. I'd be very surprised if they're that transparent to report a dump so soon.
NWBO
Paulness Paulness 4 minutes ago
NEWS -- Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

https://media.zenfs.com/en/business-wire.com/c4616f6e7aa16929b699fd932a061105

24 Month Visual Acuity Benefits from a Single Administration with OpRegen® Rep
LCTX
KVM KVM 4 minutes ago
So I think we are 6 months away if execute on pipeline and nondilutive rebalancing of Veri being a minimum $25 stock. JMO
VERI
1vman 1vman 4 minutes ago
***** More like AMC is a 22% loser of HYMC ( Hyturd ) I guess the more photoshopped pictures of NYMC the more validity they have i guess

ENOUGH SAID
AMC
Hoskuld Hoskuld 5 minutes ago
TBH I think we should all take guidance on timing with a huge grain of salt. Anavex misses 100% of its stated calendar milestones. IMO, the data for 2-73 is excellent, but management deliberately (and legally, unfortunately) shares unrealistic (for them) timelines. For example, at the ASM only 8
ASM
MightyX MightyX 5 minutes ago
Nice move $5.50 premarket..most-holders under $4 average
LUMN
Awl416 Awl416 6 minutes ago
Night night
VEV
carolinatiger carolinatiger 7 minutes ago
Like I said, thanks for the confidence of being here. Everyone will hold because of you now. You're the best.
IGPK
TrendTrade2016 TrendTrade2016 7 minutes ago
This pump is done, they will rinse the rag in the range before the next dump back to 000s
ASII
work-n-hard work-n-hard 7 minutes ago
LPSN: Interesting first look. Thanks Cross. Hope you've been well.
LPSN
RuleofK RuleofK 9 minutes ago
Sentinus merged with Rothschild at about the same time. New owner, new rules?
NWBO
dreamhouse33 dreamhouse33 9 minutes ago
Real?
NSAV
penguin007 penguin007 9 minutes ago
Ya, me too. Wish we could go back to tech bubble trading like 1999. I was making bank, and wish I would have been smarter back then. Nope, took it for granted, stuck some into my struggling business, and lost the rest. Anyway, here we are with BLEG. Let's get this moving again!
BLEG
joepcf joepcf 9 minutes ago
Earnings call was pretty impressive. Large short in the stock, maybe she gets interesting!!!!!
leverage102 leverage102 9 minutes ago
NSAVx 100's of MILLIONS Reported in Revenue 1st Quarter,. * Next quarter Revs are anticipated to be GREATER $ MULTITUDE OF DEVELOPMENTS; Including but not limited too increasing Institutions Investing on NSAVx CEX Platform.
Today or Next Week, BREAKING NEWS $$$$. DUE DILIGENCE, DO YOUR OWN.
NSAV
learningcurve2020 learningcurve2020 10 minutes ago
#9. CEO, CFO, COB plus all LP.

#10. No quarterly calls.

#11. Almost all B lost pumpers appear to be gone

#12. No institutional investors

#13. They don't appear to care about 9-13.

#14.....
NWBO
jammy32 jammy32 10 minutes ago
Hopefully we get some new soon. Best of luck to all
ELTP
Monksdream Monksdream 12 minutes ago
PGY reported
https://investorshub.advfn.com/uimage/uploads/2024/8/9/hy[dxIMG_0367.gif
PGY
ham n slam ham n slam 12 minutes ago
still holding 4 mil shares..so i hear ya....man at this point i wish theyd do a deal with anyone..buyout is a long shot...an inch of good news will make it move and then too where nobody knows...a simple pr would do something...but dont bet on that either.
VPLM
nelson1234 nelson1234 13 minutes ago
AATC looks like another solid quarter
uranium-pinto-beans uranium-pinto-beans 13 minutes ago
CyberArk price target raised to $315 from $295 at Baird
Baird raised the firm's price target on CyberArk to $315 from $295 and keeps an Outperform rating on the shares. The firm said they delivered a standout Q2, exceeding expectations and raising full-year guidance across all metrics.